Location History:
- Woodside, CA (US) (1981 - 1984)
- Palo Alto, CA (US) (1981 - 2004)
Company Filing History:
Years Active: 1981-2004
Title: The Innovative Contributions of Richard E. Jones
Introduction
Richard E. Jones is a prominent inventor based in Palo Alto, California, known for his significant contributions to the field of medical treatments, particularly in combating cellular proliferative disorders. With a total of 16 patents to his name, Jones has made remarkable strides in developing methods and compositions that enhance the efficacy of cancer treatments.
Latest Patents
Among his latest patents, Jones has developed innovative methods for treating cancer through the administration of FMdC followed by a platinate. This approach aims to improve the effectiveness of cancer therapies. Additionally, he has created gel delivery vehicles for anticellular proliferative agents, which provide methods and compositions for treating hosts suffering from cellular proliferative diseases. These methods utilize a substantially non-aqueous gel delivery vehicle that combines at least one polar organic solvent with thickening agents, thereby enhancing the efficacy of regionally or locally administered antiproliferative agents.
Career Highlights
Throughout his career, Richard E. Jones has worked with notable companies such as Matrix Pharmaceutical, Inc. and Syntex (U.S.A.) Inc. His work in these organizations has contributed to the advancement of medical treatments and has positioned him as a key figure in the field of pharmaceutical innovation.
Collaborations
Jones has collaborated with esteemed colleagues, including Richard Maskiewicz and Brian H. Vickery, further enriching his research and development efforts in the medical field.
Conclusion
Richard E. Jones exemplifies the spirit of innovation in the medical industry through his groundbreaking patents and collaborations. His work continues to impact the treatment of cancer and cellular proliferative disorders, showcasing the importance of inventive contributions in healthcare.